You are here:Home-Chemical Inhibitors & Agonists-GPCR-GPR84-GLPG1205
GLPG1205

Chemical Structure : GLPG1205

CAS No.: 1445847-37-9

GLPG1205 (GLPG 1205)

Catalog No.: PC-72356Not For Human Use, Lab Use Only.

GLPG1205 is a potent and selective GPR84 inhibitor (negative allosteric modulator) with IC50 of 54 nM (hGPR84).

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

GLPG1205 is a potent and selective GPR84 inhibitor (negative allosteric modulator) with IC50 of 54 nM (hGPR84).
GLPG1205 is fully selective over close homologs GPR43 (FFA2R) and GPR41 (FFA3R) and >100-fold selective over 123 other GPCRs on a Millipore GPCR Profiler panel.
GLPG1205 exhibits high potency in human and rat neutrophil assay with IC50 of 11 nM and 111 nM, respectively.
GLPG1205 (once-daily doses of 3 and 10 mg/kg) reduced disease activity index score and neutrophil infiltration in a mouse dextran sodium sulfate-induced chronic inflammatory bowel disease model, with efficacy similar to positive-control compound sulfasalazine.

Physicochemical Properties

M.Wt 378.428
Formula C22H22N2O4
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Month
Shipping
Solubility

Chemical Name/SMILES

References

1. Labéguère F, et al. J Med Chem. 2020 Nov 25;63(22):13526-13545.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: